tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Tourmaline Bio downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe FlyTourmaline Bio downgraded to Neutral from Buy at H.C. Wainwright
17d ago
Tourmaline Bio downgraded to Hold from Buy at Truist
Premium
The Fly
Tourmaline Bio downgraded to Hold from Buy at Truist
18d ago
Tourmaline Bio downgraded to Neutral from Buy at Chardan
Premium
The Fly
Tourmaline Bio downgraded to Neutral from Buy at Chardan
18d ago
Tourmaline Bio downgraded to Neutral from Buy at Guggenheim
PremiumThe FlyTourmaline Bio downgraded to Neutral from Buy at Guggenheim
18d ago
Tourmaline Bio downgraded to Neutral from Outperform at Wedbush
Premium
The Fly
Tourmaline Bio downgraded to Neutral from Outperform at Wedbush
18d ago
Novartis Seals $1.4B Deal with Tourmaline Bio (TRML) to Bolster Heart Disease Portfolio
Premium
Market News
Novartis Seals $1.4B Deal with Tourmaline Bio (TRML) to Bolster Heart Disease Portfolio
18d ago
Tourmaline Bio presents data from ongoing Phase 2 TRANQUILITY trial
PremiumThe FlyTourmaline Bio presents data from ongoing Phase 2 TRANQUILITY trial
26d ago
Tourmaline Bio’s Strategic Advancements and Promising Clinical Trial Results Reinforce Buy Rating
Premium
Ratings
Tourmaline Bio’s Strategic Advancements and Promising Clinical Trial Results Reinforce Buy Rating
1M ago
Tourmaline Bio’s Promising Developments and Strategic Potential: Analyst Recommends ‘Buy’ Rating
Premium
Ratings
Tourmaline Bio’s Promising Developments and Strategic Potential: Analyst Recommends ‘Buy’ Rating
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100